1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
IOL Chemicals and Pharmaceuticals Limited

IOL Chemicals and Pharmaceuticals Limited

IOLCP.NS
IOL Chemicals and Pharmaceuticals LimitedIN flagNational Stock Exchange of India
144.46
INR
+1.50
- -
42.40BMarket Cap

Total Valuation

IOL Chemicals and Pharmaceuticals Limited carries a market capitalization of 42.40B, placing it among publicly traded companies globally. Its enterprise value stands at 20.62B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap42.40B
Enterprise Value20.62B

Share Statistics

IOL Chemicals and Pharmaceuticals Limited currently has 293.53M shares outstanding.

Shares Outstanding293.53M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

IOL Chemicals and Pharmaceuticals Limited trades at a trailing price-to-earnings ratio of 15.52. The price-to-sales ratio is 0.92, and the price-to-book ratio stands at 36.38.

PE Ratio15.52
PS Ratio0.92
PB Ratio36.38
P/TBV Ratio1.20
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, IOL Chemicals and Pharmaceuticals Limited trades at an EV/EBITDA multiple of 10.93 and an EV/FCF ratio of 189.95. The EV/Sales ratio of 0.89 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.93 provides insight into valuation relative to core operating earnings.

EV / Sales0.89
EV / EBITDA10.93
EV / EBIT10.93
EV / FCF189.95

Financial Position

IOL Chemicals and Pharmaceuticals Limited maintains a current ratio of 1.78, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 7.53, indicating elevated leverage, while an interest coverage ratio of 12.97 demonstrates strong ability to service its debt obligations.

Current Ratio1.78
Quick Ratio0.30
Debt / Equity7.53
Debt / EBITDA0.72
Interest Coverage12.97

Financial Efficiency

IOL Chemicals and Pharmaceuticals Limited posts a return on equity of 18.12 and a return on invested capital of 7.53.

Return on Equity (ROE)18.12
Return on Assets (ROA)5.54
Return on Invested Capital (ROIC)7.53
Return on Capital Employed (ROCE)16.76
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover4.07

Taxes

Over the trailing twelve months, IOL Chemicals and Pharmaceuticals Limited has paid 467.20M in income taxes, reflecting an effective tax rate of 25.34.

Income Tax467.20M
Effective Tax Rate25.34

Stock Price Statistics

IOL Chemicals and Pharmaceuticals Limited's stock has gained approximately 52.60934% over the past 52 weeks. The 50-day moving average sits at 121.09, while the 200-day moving average is 92.76.

Beta (5Y)N/A
52-Week Price Change52.60934%
50-Day Moving Average121.09
200-Day Moving Average92.76
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, IOL Chemicals and Pharmaceuticals Limited generated 23.19B in revenue and converted that into 1.38B in net income, yielding earnings per share of 4.69. EBITDA reached 1.89B, while operating income came in at 1.89B.

Revenue23.19B
Gross Profit8.32B
Operating Income1.89B
Pretax Income1.84B
Net Income1.38B
EBITDA1.89B
EBIT1.89B
Earnings Per Share (EPS)4.69

Balance Sheet

IOL Chemicals and Pharmaceuticals Limited holds 2.09B in cash and equivalents against 1.35B in total debt, resulting in a net debt position of 666.50M. Total book value stands at 587.10M, with working capital of 5.37B providing operational flexibility.

Cash & Cash Equivalents2.09B
Total Debt1.35B
Net Debt666.50M
Equity (Book Value)587.10M
Book Value Per Share2.00
Working Capital5.37B

Margins

IOL Chemicals and Pharmaceuticals Limited operates with a gross margin of 35.87, reflecting its pricing power and cost economics. The operating margin of 8.13 and net profit margin of 5.94 provide insight into operational efficiency.

Gross Margin35.87
Operating Margin8.13
Pretax Margin7.95
Profit Margin5.94
EBITDA Margin8.13

Stock Splits

IOL Chemicals and Pharmaceuticals Limited's most recent stock split took place on March 11, 2025 with a 1:5 split ratio.

Last Split Date3/11/2025
Split Ratio1:5

Scores

IOL Chemicals and Pharmaceuticals Limited posts an Altman Z-Score of 3.02, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.02